MedTrace Logo

Evaluate the Efficacy and Safety of ACP-044 for the Treatment of Acute Postoperative Pain Following Bunionectomy

NCT04855240 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 239

Last updated 2023-05-03

Study results available
· View outcomes & findings →

Summary

To evaluate the efficacy of ACP-044 compared with placebo in the treatment of acute postoperative pain

Conditions

  • Acute Postoperative Pain
  • Bunionectomy

Interventions

DRUG

ACP-044 Dose A

Oral dose of ACP-044 Dose A

DRUG

ACP-044 Dose B

Oral dose of ACP-044 Dose B

DRUG

Placebo

Oral dose of placebo

Sponsors & Collaborators

  • ACADIA Pharmaceuticals Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-29
Primary Completion
2022-02-11
Completion
2022-03-14
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04855240 on ClinicalTrials.gov